Biotech news for Monday, June 8, 2026, ranked by our 5-dimension investment framework — regulatory, technology, commercial, manufacturing, and narrative.
JHVEPhoto/iStock Editorial via Getty Images Incyte Corp. ( INCY ) is close to acquiring privately held Star Therapeutics in a deal valued at up to $2 billion, the Financial Times reported Sunday, citing people familiar with the matter, as midsized drugmakers c…
Kateryna Borodina/iStock via Getty Images Additional data from a phase 2 study of Zealand Pharma's ( ZLDPF ) petrelintide indicated that the amylin analog led to significant weight loss over 42 weeks of treatment. Active-arm participants in the placebo-control…
Greggory DiSalvo Senior U.S. officials have held preliminary discussions with major AI companies about the possibility of the federal government acquiring equity stakes in AI firms, according to a report by NOTUS that cites three people familiar with the matte…
Gilead Sciences ( GILD ) and Lakefront Biotherapeutics ( LKFT ) have completed their acquisition of Ouro Medicines, providing the two companies with a better foothold in T cell engager therapies for autoimmune diseases. Gamgertamig (OM336), a phase 1 BCMAxCD3…
Dougal Waters Wall Street ended mixed Thursday as Broadcom ( AVGO ) results disappointed traders and pulled down other chip names, while eyes remained on the Middle East conflict as oil ( CL1:COM ) ( CO1:COM ) prices and Treasury yields both pulled back. S&…
Bio Green Med Solution ( NASDAQ: BGMS ) entered into a business combination agreement to acquire Future NRG Sdn. Bhd. through an all-stock share exchange. Future NRG is a Malaysia-based technology integrator focused on sustainable medical waste management and…
JHVEPhoto Alvotech ( ALVO ) shares spiked on Thursday after the company announced the resubmission of U.S. marketing applications for biosimilars AVT05 and AVT06 targeting Johnson & Johnson’s ( JNJ ) Simponi and Regeneron’s ( REGN ) Eylea, respectively. AV…
Mindaugas Dulinskas The Supreme Court unanimously sided with generic drugmaker Hikma ( HKMPF ) and against Amarin Corp. ( AMRN ) in a case dealing with narrower labels for generic products compared to their brand equivalents, colloquially known as "skinny labe…
Bitcoin ( BTC-USD ) price hovered around the $77k to $80k range in May, with prices further declining in June. The cryptocurrency market has erased more than $2T in value since reaching a record high in October 2025 and is now down 48% from that peak, accordin…
IURII KRASILNIKOV/iStock via Getty Images Shares of Iovance Biotherapeutics ( IOVA ) climbed on Thursday after the Therapeutic Goods Administration of Australia granted conditional approval for the company’s cell therapy, Amtagvi, as a late-line option for the…
alexsl Absci ( ABSI ) shares reached the highest level in more than four years on Thursday after Leerink Partners initiated its coverage with an Outperform recommendation, noting that the AI-focused drug developer has one of the most attractive catalyst paths…
angelp Three scientific papers used by Health and Human Services Secretary Robert F. Kennedy Jr. and his allies to justify changes to the U.S. vaccination policy are facing fresh scrutiny, The Guardian reported on Thursday. The journals that published the pape…
Worawith Ounpeng Parabilis Medicines ( PBLS ), a cancer drug developer backed by a recent research collaboration with Regeneron ( REGN ), has announced plans to raise up to $476M from its initial public offering in the U.S. According to an amended S-1 filing s…
IMUNON ( IMNN ) announced on Thursday that it has entered into definitive agreements with expected aggregate gross proceeds to the company in the amount of $10 million. The transaction includes 250 shares of non-redeemable, non-convertible preferred stock for…
vzphotos/iStock Editorial via Getty Images The U.K.'s National Health Service will start to offer AbbVie’s ( ABBV ) ovarian cancer therapy Elahere following a recommendation by the health spending watchdog, National Institute for Health and Care Excellence (NI…
Commercial-stage biopharmaceutical company Syndax Pharmaceuticals ( SNDX ) entered into privately negotiated agreements for the issuance of $250M 2.25% convertible senior notes due 2031. The sale of the notes is expected to close on June 10, 2026. Net proceeds…